跳至主要内容
临床试验/NCT03483389
NCT03483389已完成不适用

Immune Activation and Neurodegeneration in HIV Infection and Heavy Drinking

Brown University1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2018年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
76
试验地点
1
主要终点
Plasma lipopolysaccharide binding protein (ng/ml)

研究概览

简要总结

This study investigates how alcohol affects the immune system and behavior in healthy adults. The study also will examine how an individual's typical drinking habits may affect the immune system's response to alcohol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Ages 21-55 years
  • Able to speak and read English
  • Regular use of alcohol
  • Weight > or = to 110 lbs and body mass index (BMI) in the 18.5-30 kg/m2 range
  • No self-reported use of drugs

排除标准

  • Currently seeking treatment for alcohol or drug use
  • Chronic disease
  • Use of certain medications
  • GI disorders
  • Daily/near-daily use of NSAIDs
  • Positive urine test for certain drugs
  • History of withdrawal symptoms precipitated by alcohol abstinence
  • Clinical Institute Withdrawal Assessment for Alcohol score greater than or equal to 10
  • History of seizures
  • Current major psychiatric disorder
  • History of adverse reaction to standard blood draw
  • Inability to abstain from tobacco for 8 hours
  • Inability to abstain from cannabis for 48 hours
  • Pregnant, breastfeeding, or may become pregnant

研究组 & 干预措施

Alcohol, placebo

Experimental

Alcohol, ethyl - Placebo

干预措施: Alcohol, Ethyl (Drug)

Alcohol, placebo

Experimental

Alcohol, ethyl - Placebo

干预措施: Alcohol, Ethyl - placebo (Other)

Alcohol, low dose

Experimental

Alcohol, ethyl - Low dose

干预措施: Alcohol, Ethyl (Drug)

Alcohol, low dose

Experimental

Alcohol, ethyl - Low dose

干预措施: Alcohol, Ethyl - placebo (Other)

Alcohol, moderate dose

Experimental

Alcohol, ethyl - Moderate dose

干预措施: Alcohol, Ethyl (Drug)

Alcohol, moderate dose

Experimental

Alcohol, ethyl - Moderate dose

干预措施: Alcohol, Ethyl - placebo (Other)

结局指标

主要结局

Plasma lipopolysaccharide binding protein (ng/ml)

时间窗: 0-4 hours

Plasma concentration of lipopolysaccharide binding protein, measured in nanograms/ml

Soluble cluster of differentiation 14 (ng/ml)

时间窗: 0-4 hours

Plasma concentration of soluble cluster of differentiation 14, measured in nanograms/ml

Soluble cluster of differentiation 163 (ng/ml)

时间窗: 0-4 hours

Plasma concentration of soluble cluster of differentiation 163, measured in nanograms/ml

Plasma lipopolysaccharide (pg/ml)

时间窗: 0-4 hours

Plasma concentration of lipopolysaccharide, measured in picograms/ml

次要结局

  • Response time in ms(0-4 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mollie Monnig

Assistant Professor of Behavioral and Social Sciences

Brown University

研究点 (1)

Loading locations...

相似试验